Predictive value of predischarge spectral tissue doppler echocardiography and N-terminal pro-B-type natriuretic peptide in patients hospitalized with acute heart failure

Echocardiography

Volumn 28, Issue 3, 2011, Pages 303-310

  Ho, Shuenn Jiin ^a,c   Feng, An Ning ^b   Lee, Li Na ^b   Chen, Jaw Wen ^a,c   Lin, Shing Jong ^a,c  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b CHENG HSIN GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

biomarkers; E E ratio; heart failure; prognosis; tissue Doppler imaging

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; TROPONIN I;

ACUTE HEART FAILURE; ADULT; AGED; ARTICLE; CARDIAC PATIENT; FEMALE; FOLLOW UP; HEART DEATH; HEART HEMODYNAMICS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; SYSTOLIC BLOOD PRESSURE; TISSUE DOPPLER IMAGING; UNIVARIATE ANALYSIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ECHOCARDIOGRAPHY; ELASTICITY IMAGING TECHNIQUES; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREVALENCE; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TAIWAN;

EID: 79952748457     PISSN: 07422822     EISSN: 15408175     Source Type: Journal    
DOI: 10.1111/j.1540-8175.2010.01322.x     Document Type: Article

References (30)

1. Howlett JG,: Current treatment options for early management in acute decompensated heart failure. Can J Cardiol 2008; 24 (SupplB): 9B-14B.
2. Joseph SM, Cedars AM, Ewald GA, et al,: Acute decompensated heart failure: Contemporary medical management. Tex Heart Inst J 2009; 36 (6): 510-520.
3. Baker DW, Einstadter D, Husak SS, et al,: Trends in postdischarge mortality and readmissions: Has length of stay declined too far? Arch Intern Med 2004; 164 (5): 538-544. (Pubitemid 38314450)
4. Fonarow GC, Heywood JT, Heidenreich PA, et al,: Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: Findings from Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2007; 153 (6): 1021-1028. (Pubitemid 46809844)
5. Fang J, Mensah GA, Croft JB, et al,: Heart failure-related hospitalization in the U.S. 1979 to 2004. J Am Coll Cardiol 2008; 52 (6): 428-434. (Pubitemid 352040814)
6. Adams Jr KF, Fonarow GC, Emerman CL, et al,: Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 2005; 149: 209-216. (Pubitemid 40348525)
7. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008; 10 (10): 933-989.
8. Jessup M, Abraham WT, Casey DE, et al,: 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009; 119 (14): 1977-2016.
9. Kirkpatrick JN, Vannan MA, Narula J, et al,: Echocardiography in heart failure: Applications, utility, and new horizons. J Am Coll Cardiol 2007; 50: 381-396. (Pubitemid 47088124)
10. Toughton RW, Prior DL, Frampton CM, et al,: Usefulness of tissue Doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT Study). Am J Cardiol 2005; 96: 257-262. (Pubitemid 40978585)
11. Hamdan A, Shapira Y, Bengal T, et al,: Tissue Doppler imaging in patients with advanced heart failure: Relation to functional class and prognosis. J Heart Lung Transplant 2006; 25: 214-218.
12. Groban L, Sanders DM, Houle TT, et al,: Prognostic value of tissue Doppler-derived E/e' on early morbid events after cardiac surgery. Echocardiography 2010; 27: 131-138.
13. Masson S, Latini R, Anand IS,: An update on cardiac troponins as circulating biomarkers in heart failure. Curr Heart Fail Rep 2010; 7 (1): 15-21.
14. Buchner S, Jungbauer C, Birner C, et al,: Comparison of the cardiac markers B-type natriuretic peptide and N-terminal pro B-type natriuretic peptide. Biomark Med 2009; 3 (5): 465-481.
15. Karaahmet T, Tigen K, Dundar C, et al,: The effect of cardiac fibrosis on left ventricular remodeling, diastolic dysfunction, and N-terminal pro-B-type natriuretic peptide levels in patients with nonischemic dilated cardiomyopathy. Echocardiography 2010; 27: 954-960.
16. Yin WH, Chen JW, Jen HL, et al,: Independent prognostic value of elevated high-sensitivity C-reactive protein in chronic heart failure. Am Heart J 2004; 147: 931-938.
17. Anand IS, Latini R, Florea VG, et al,; Val-HeFT Investigators: C-reactive protein in heart failure: Prognostic value and the effect of valsartan. Circulation 2005; 112: 1428-1434. (Pubitemid 41291768)
18. Braunwald E,: Biomarkers ion heart failure. N Engl J Med 2008; 358: 2148-2159.
19. Emdin M, Vittorini S, Passino C, et al,: Old and new biomarkers of heart failure. Eur J Heart Fail 2009; 11 (4): 331-335.
20. Yin WH, Chen JW, Feng AN, et al,: Multimarker approach to risk stratification among patients with advanced chronic heart failure. Clin Cardiol 2007; 30 (8): 397-402.
21. Gottdiener JS, Bednarz J, Devereux R,: American Society of Echocardiography. American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr 2004; 17: 1086-1119.
22. The Chamber Quantification Writing Group: Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-1463.
23. Rudski LG, Lai WW, Afilalo J, et al,: Guidelines for the echocardiographic assessment of the right heart in adults: A report from the American Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685-713.
24. Shin HW, Kim H, Son J, et al,: Tissue Doppler imaging as a prognostic marker for cardiovascular events in heart failure with preserved ejection fraction and atrial fibrillation. J Am Soc Echocardiogr 2010; 23: 755-761.
25. Mann DL,: Mechanisms and models in heart failure: A combinatorial approach. Circulation 1999; 100: 999-1008. (Pubitemid 29407182)
26. Galvani M, Ferrini D, Ghezzi F, et al,: Cardiac markers and risk stratification: An integrated approach. Clin Chim Acta 2001; 311: 9-17. (Pubitemid 32842455)
27. Sabatine MS, Morrow DA, de Lemos JA, et al,: Multimarker approach to risk stratification in non-ST elevation acute coronary syndrome: Simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide. Circulation 2002; 105: 1760-1763. (Pubitemid 34408881)
28. Dokainish H, Zoghbi WA, Lakkis NM, et al,: Incremental predictive power of B-type natriuretic peptide and tissue Doppler echocardiography in the prognosis of patients with congestive heart failure. J Am Coll Cardiol 2005; 45: 1223-1226. (Pubitemid 40523141)
29. Hamada Y, Tanaka N, Murata K, et al,: Significance of predischarge BNP on one-year outcome in decompensated heart failure-Comparative study with echo-Dopper indexes. J Card Fail 2005; 11: 43-49. (Pubitemid 40215313)
30. Wasywich CA, Whalley GA, Walsh HA, et al,: The relationship between BNP and E/Ea in patients hospitalized with acute heart failure. Int J Cardiol 2008; 125: 280-282. (Pubitemid 351410435)